F-group (family)
7575.1.1.1 Peptidase_C14
Ligands and drugs
971
Member domains
269
with ligand contacts (≤ 4 Å)
27.7% of members
251
with DrugDomain annotations
25.8% of members
99
with a DrugBank compound
10.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7575.1.1.1 belongs to X-group 7575 Caspase-like, which binds 7.0 ligand superclasses per 20 proteins, narrower than 60% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04447 | DTT | 1,4-Dithiothreitol | 12 |
| DB01822 | DTD | (4R,5R)-1,2-dithiane-4,5-diol | 3 |
| DB05408 | — | — | 3 |
| DB06255 | — | — | 3 |
| DB00282 | — | Pamidronic acid | 2 |
| DB00945 | — | Acetylsalicylic acid | 2 |
| DB01017 | — | Minocycline | 2 |
| DB03124 | 161 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | 2 |
| DB03384 | FXN | Fica | 2 |
| DB07696 | DZE | methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate | 2 |
| DB08251 | NA4 | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID | 2 |
| DB08497 | RXB | (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate | 2 |
| DB08498 | RXC | (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate | 2 |
| DB08499 | RXD | N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide | 2 |
| DB12843 | — | — | 2 |
| DB04297 | — | Trichostatin A | 1 |
| DB04875 | — | — | 1 |
| DB05103 | — | — | 1 |
| DB07733 | F1G | 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE | 1 |
| DB07744 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 35 |
| AZI | AZIDE ION | 34 |
| NAmetal | SODIUM ION | 33 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 12 |
| MRD | (4R)-2-METHYLPENTANE-2,4-DIOL | 10 |
| UCI | (3R,5S)-1-(ethanesulfonyl)-5-phenyl-N-[4-(trifluoromethoxy)phenyl]piperidine-3-carboxamide (bound form) | 8 |
| US9 | (3R)-1-(ethanesulfonyl)-N-[4-(trifluoromethoxy)phenyl]piperidine-3-carboxamide | 8 |
| 2GQ | 3-(pyrrolidin-1-yl)isoquinolin-1(2H)-one | 6 |
| CAmetal | CALCIUM ION | 6 |
| MGmetal | MAGNESIUM ION | 5 |
| A1AAB | N-{7-[(1S)-1-methoxyethyl]-2-methyl[1,3]thiazolo[5,4-b]pyridin-6-yl}-N'-[6-(2H-1,2,3-triazol-2-yl)-5-(trifluoromethyl)pyridin-3-yl]urea | 4 |
| DTD | DITHIANE DIOL | 4 |
| ZNmetal | ZINC ION | 4 |
| 158 | 3-(2-MERCAPTO-ACETYLAMINO)-4-OXO-PENTANOIC ACID | 3 |
| 8YJ | 2-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}benzoic acid | 3 |
| 0TE | chloro{methyl hydrogenato(3-)-kappa~2~N,S [pyridin-2-yl(pyridin-2(1H)-ylidene-kappaN)methyl]carbonodithiohydrazonate}copper | 2 |
| 0ZZ | 5-S-benzyl-3-({N-[(5-bromo-2-methoxyphenyl)acetyl]-L-valyl}amino)-2,3-dideoxy-5-thio-D-erythro-pentonic acid | 2 |
| 160 | 3-(3-{2-[(5-METHANESULFONYL-THIOPHENE-2-CARBONYL)-AMINO]-ETHYLDISULFANYLMETHYL}- BENZENESULFONYLAMINO)-4-OXO-PENTANOIC ACID | 2 |
| 161 | 5-[4-(1-CARBOXYMETHYL-2-OXO-PROPYLCARBAMOYL)-BENZYLSULFAMOYL]-2-HYDROXY-BENZOIC ACID | 2 |
| 2FQ | 6-amino-2,8-dimethylpyrido[2,3-d]pyrimidin-7(8H)-one | 2 |